Reducing inflammation protects against early age-related macular degeneration-like vision loss

Reducing chronic inflammation shows promise in protecting against early age-related macular degeneration-like vision loss in preclinical models. University of Minnesota researchers found that targeting inflammation prevented key signs of early retinal disease, including immune cell infiltration and deposit formation. This approach focuses on early intervention. AMD is a leading cause of vision loss in older Americans. This research could lead to new preventive treatments for the condition affecting millions.